CME Group Inc. (NASDAQ:CME) Shares Purchased by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC increased its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 7.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,637 shares of the financial services provider’s stock after acquiring an additional 724 shares during the period. Motley Fool Asset Management LLC’s holdings in CME Group were worth $2,290,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Second Half Financial Partners LLC purchased a new position in CME Group in the 4th quarter valued at about $2,737,000. Naples Global Advisors LLC lifted its stake in CME Group by 5.6% in the 4th quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock valued at $436,000 after buying an additional 110 shares in the last quarter. Sapient Capital LLC purchased a new position in CME Group in the 4th quarter worth approximately $1,823,000. Raymond James Financial Services Advisors Inc. lifted its stake in CME Group by 2.3% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 1,041,526 shares of the financial services provider’s stock worth $224,230,000 after purchasing an additional 23,340 shares in the last quarter. Finally, Bluefin Capital Management LLC purchased a new position in CME Group in the 4th quarter worth approximately $2,891,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the transaction, the director now owns 7,163 shares in the company, valued at $1,399,936.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CEO Terrence A. Duffy sold 40,000 shares of the business’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $210.91, for a total value of $8,436,400.00. Following the completion of the sale, the chief executive officer now directly owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The disclosure for this sale can be found here. Insiders sold a total of 54,290 shares of company stock worth $11,393,700 over the last 90 days. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Keefe, Bruyette & Woods reissued a “market perform” rating and issued a $226.00 target price on shares of CME Group in a research note on Wednesday, July 3rd. Bank of America raised their target price on shares of CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a research note on Thursday, April 25th. Piper Sandler decreased their target price on shares of CME Group from $250.00 to $235.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 9th. Barclays decreased their target price on shares of CME Group from $228.00 to $208.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 10th. Finally, Rosenblatt Securities reaffirmed a “sell” rating and set a $187.00 price target (up previously from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $215.82.

Read Our Latest Stock Report on CME Group

CME Group Trading Up 2.1 %

CME Group stock traded up $4.09 during trading on Wednesday, hitting $201.46. The company had a trading volume of 1,834,357 shares, compared to its average volume of 1,972,519. CME Group Inc. has a 1-year low of $184.96 and a 1-year high of $223.80. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The company’s 50 day simple moving average is $201.71 and its 200-day simple moving average is $207.22. The stock has a market cap of $72.54 billion, a price-to-earnings ratio of 22.55, a price-to-earnings-growth ratio of 5.32 and a beta of 0.52.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter last year, the firm earned $2.42 EPS. The firm’s revenue for the quarter was up 3.2% on a year-over-year basis. As a group, analysts expect that CME Group Inc. will post 9.77 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were paid a $1.15 dividend. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.28%. CME Group’s dividend payout ratio (DPR) is 52.33%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.